BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 18785379)

  • 1. Citrus aurantium--beware of the bitter orange.
    Louw VJ; Louw H
    S Afr Med J; 2008 Jul; 98(7):496. PubMed ID: 18785379
    [No Abstract]   [Full Text] [Related]  

  • 2. The safety of Citrus aurantium (bitter orange) and its primary protoalkaloid p-synephrine.
    Stohs SJ; Preuss HG; Shara M
    Phytother Res; 2011 Oct; 25(10):1421-8. PubMed ID: 21480414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible association of acute lateral-wall myocardial infarction and bitter orange supplement.
    Nykamp DL; Fackih MN; Compton AL
    Ann Pharmacother; 2004 May; 38(5):812-6. PubMed ID: 15026566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bitter orange weight loss products may not be safe.
    Health News; 2004 Dec; 10(12):9. PubMed ID: 15645567
    [No Abstract]   [Full Text] [Related]  

  • 5. Review of Published Bitter Orange Extract and
    Stohs SJ; Ray SD
    J Diet Suppl; 2020; 17(3):355-363. PubMed ID: 30835576
    [No Abstract]   [Full Text] [Related]  

  • 6. Products containing bitter orange or synephrine: suspected cardiovascular adverse reactions.
    Jordan S; Murty M; Pilon K
    CMAJ; 2004 Oct; 171(8):993-4. PubMed ID: 15497209
    [No Abstract]   [Full Text] [Related]  

  • 7. Safety, Efficacy, and Mechanistic Studies Regarding Citrus aurantium (Bitter Orange) Extract and p-Synephrine.
    Stohs SJ
    Phytother Res; 2017 Oct; 31(10):1463-1474. PubMed ID: 28752649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of the human clinical studies involving Citrus aurantium (bitter orange) extract and its primary protoalkaloid p-synephrine.
    Stohs SJ; Preuss HG; Shara M
    Int J Med Sci; 2012; 9(7):527-38. PubMed ID: 22991491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ephedra-free is not danger-free.
    Marcus DM; Grollman AP
    Science; 2003 Sep; 301(5640):1669-71; author reply 1669-71. PubMed ID: 14500960
    [No Abstract]   [Full Text] [Related]  

  • 10. A 60day double-blind, placebo-controlled safety study involving Citrus aurantium (bitter orange) extract.
    Kaats GR; Miller H; Preuss HG; Stohs SJ
    Food Chem Toxicol; 2013 May; 55():358-62. PubMed ID: 23354394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Synephrine in dietary supplements and specialized foodstuffs: biological activity, safety and methods of analysis].
    Perova IB; Eller KI; Musatov AV; Tymolskaya EV
    Vopr Pitan; 2021; 90(6):101-113. PubMed ID: 35032130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of citrus aurantium for weight loss.
    Bent S; Padula A; Neuhaus J
    Am J Cardiol; 2004 Nov; 94(10):1359-61. PubMed ID: 15541270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Risk assessment of synephrine in dietary supplements].
    Bakhyia N; Dusemund B; Richter K; Lindtner O; Hirsch-Ernst KI; Schäfer B; Lampen A
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Mar; 60(3):323-331. PubMed ID: 28058460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Citrus aurantium (bitter orange) fruit extracts and p-synephrine on metabolic fluxes in the rat liver.
    Peixoto JS; Comar JF; Moreira CT; Soares AA; de Oliveira AL; Bracht A; Peralta RM
    Molecules; 2012 May; 17(5):5854-69. PubMed ID: 22592089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rapid liquid chromatography electrospray ionization mass spectrometry(n) method for evaluation of synephrine in Citrus aurantium L. samples.
    Mattoli L; Cangi F; Maidecchi A; Ghiara C; Tubaro M; Traldi P
    J Agric Food Chem; 2005 Dec; 53(26):9860-6. PubMed ID: 16366666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiological effects following administration of Citrus aurantium for 28 days in rats.
    Hansen DK; George NI; White GE; Pellicore LS; Abdel-Rahman A; Fabricant D;
    Toxicol Appl Pharmacol; 2012 Jun; 261(3):236-47. PubMed ID: 22521485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concentrations of p-synephrine in fruits and leaves of Citrus species (Rutaceae) and the acute toxicity testing of Citrus aurantium extract and p-synephrine.
    Arbo MD; Larentis ER; Linck VM; Aboy AL; Pimentel AL; Henriques AT; Dallegrave E; Garcia SC; Leal MB; Limberger RP
    Food Chem Toxicol; 2008 Aug; 46(8):2770-5. PubMed ID: 18571300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unsupported conclusions in the article "Synephrine-containing dietary supplement precipitating apical ballooning syndrome in a young female".
    Stohs SJ
    Korean J Intern Med; 2014 May; 29(3):388-92. PubMed ID: 24851076
    [No Abstract]   [Full Text] [Related]  

  • 19. Mass spectrometric determination of the predominant adrenergic protoalkaloids in bitter orange (Citrus aurantium).
    Nelson BC; Putzbach K; Sharpless KE; Sander LC
    J Agric Food Chem; 2007 Nov; 55(24):9769-75. PubMed ID: 17966980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular Safety of Oral p-Synephrine (Bitter Orange) in Healthy Subjects: A Randomized Placebo-Controlled Cross-over Clinical Trial.
    Shara M; Stohs SJ; Mukattash TL
    Phytother Res; 2016 May; 30(5):842-7. PubMed ID: 26948284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.